Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment (Q35358467)

7 August 2017

Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment (English)

1 reference

primary biliary cholangitis

7 August 2017

0 references

author name string

Leuschner M

1

1 reference

7 August 2017

Dietrich CF

2

1 reference

7 August 2017

You T

3

1 reference

7 August 2017

Seidl C

4

1 reference

7 August 2017

Raedle J

5

1 reference

7 August 2017

Herrmann G

6

1 reference

7 August 2017

Ackermann H

7

1 reference

7 August 2017

Leuschner U

8

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

7 August 2017

1 reference

7 August 2017

46

1 reference

7 August 2017

1

1 reference

7 August 2017

121-126

1 reference

Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis

7 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727784

Ursodeoxycholate stabilizes phospholipid-rich membranes and mimics the effect of cholesterol: investigations on large unilamellar vesicles

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727784

Effect of deoxycholic acid and ursodeoxycholic acid on lipid peroxidation in cultured macrophages

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727784

Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727784

Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727784

The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727784

Effects of ursodeoxycholic acid after 4 to 12 years of therapy in early and late stages of primary biliary cirrhosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727784

Characterisation of patients with a complete biochemical response to ursodeoxycholic acid

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727784

Measuring the strength of associations between HLA antigens and diseases

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727784

HL-A antigens and disease. Statistical and genetical considerations.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727784

Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727784

A simple salting out procedure for extracting DNA from human nucleated cells

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727784

Prognosis in primary biliary cirrhosis: model for decision making

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727784

Rapid HLA-DRB1 genotyping by nested PCR amplification.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727784

Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727784

Adjuvant cholylsarcosine during ursodeoxycholic acid treatment of primary biliary cirrhosis.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727784

p53 expression in patients with cirrhosis with and without hepatocellular carcinoma

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727784

A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1727784

Antimitochondrial antibody profiles in primary biliary cirrhosis distinguish at early stages between a benign and a progressive course: a prospective study on 200 patients followed for 10 years

26 September 2018

1 reference

12 December 2020

Natural course of primary biliary cirrhosis. I. A morphological, clinical and serological analysis of 103 cases

1 reference

12 December 2020

Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosis

1 reference

12 December 2020

Microdroplet Assay of Human Serum Cytotoxins

1 reference

12 December 2020

High performance liquid chromatographic determination of free and conjugated bile acids in serum, liver biopsies, bile, gastric juice and feces by fluorescence labeling

1 reference

12 December 2020

Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial

1 reference

12 December 2020

Molecular aspects of membrane stabilization by ursodeoxycholate [see comment]

1 reference

12 December 2020

Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis

1 reference

12 December 2020

Toxicity of bile acids on the electron transport chain of isolated rat liver mitochondria

1 reference

12 December 2020

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis

1 reference

12 December 2020

Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers

1 reference

12 December 2020

Ursodeoxycholate protects oxidative mitochondrial metabolism from bile acid toxicity: dose-response study in isolated rat liver mitochondria

1 reference

12 December 2020

Autoimmune cholangitis: a variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases

1 reference

12 December 2020

Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes

1 reference

12 December 2020

Bile acid concentrations in human and rat liver tissue and in hepatocyte nuclei

1 reference

12 December 2020

Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation

1 reference

12 December 2020

Identifiers

DOI

10.1136/GUT.46.1.121

1 reference

7 August 2017

1 reference

7 August 2017

1 reference